Overview

Efficacy and Safety of LEO 90100 Foam in Japanese Subjects With Psoriasis Vulgaris

Status:
Completed
Trial end date:
2019-06-10
Target enrollment:
Participant gender:
Summary
Comparison of the efficacy of LEO 90100 foam with Dovobet® ointment in the treatment of psoriasis in Japanese subjects.
Phase:
Phase 3
Details
Lead Sponsor:
LEO Pharma
Treatments:
Betamethasone-17,21-dipropionate